§ Mr. BarronTo ask the Secretary of State for Health what discussions have taken place with(a) representatives of NICE, (b) representatives of patients' groups, (c) representatives of professional groups, (d) representatives of the pharmaceutical industry, (e) representatives of health authorities and trusts and other health organisations as part of the preparatory work in relation to the review of NICE; and if he will make a statement. [20157]
§ Ms Blears[holding answer 3 December 2001]: As part of routine business we have held a number of discussions on this subject, particularly with the National Institute for Clinical Excellence and the pharmaceutical industry.
We expect shortly to issue a consultation document on aspects of the NICE appraisal process. The document will be limited in scope, taking account of the review already undertaken in the Bristol Royal Infirmary Inquiry and the current inquiry by the Health Select Committee.